Literature DB >> 19639203

Intracellular localization of survivin determines biological behavior in colorectal cancer.

Guangying Qi1, Handan Tuncel, Eriko Aoki, Shinji Tanaka, Sirou Oka, Iwao Kaneko, Mayumi Okamoto, Maasaki Tatsuka, Shiro Nakai, Fumio Shimamoto.   

Abstract

Survivin is a bifunctional protein that suppresses apoptosis and regulates cell division and is highly expressed in various human cancers. Recently, the intracellular localization of survivin in tumors has been suggested as a prognostic marker, but the molecular mechanisms are not understood. The aims of the present study were to investigate the different localization of survivin expression in colorectal carcinoma and expression of survivin relationships with clinicopathological factors and patient survival. Immunohistochemical analyses of 142 cases of advanced colorectal cancer showed that 109 (76.8%) cases expressed survivin in the nucleus and 29 cases (20.4%) in the cytoplasm. Cytoplasmic survivin overexpression was associated with a poor prognosis, but nuclear survivin overexpression was associated with a better prognosis. Subcellular distribution of survivin in five cases of cancerous or surrounding normal tissues derived from fresh biopsy of non-fixed samples of colorectal cancer patients was further demonstrated by Western blotting. Survivin was primarily found in the insoluble fraction. Interestingly, regardless of survivin protein levels in the insoluble fraction, patients who had cancerous tissue expressing cytoplasmic and nuclear soluble survivin suffered from lymph nodes metastases. These data suggest that the function of cytoplasmic survivin might be important for malignant progress and the levels of cytoplasmic and nuclear soluble survivin might be more relevant for prognostic factors for colorectal cancer than the total amount of survivin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19639203     DOI: 10.3892/or_00000471

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  17 in total

1.  Survivin and pancreatic cancer.

Authors:  Bin-Bin Liu; Wei-Hong Wang
Journal:  World J Clin Oncol       Date:  2011-03-10

2.  Expression of survivin, MUC2 and MUC5 in colorectal cancer and their association with clinicopathological characteristics.

Authors:  Haipeng Wang; Shengjian Jin; Huiling Lu; Sisi Mi; Wenhua Shao; Xiaoxv Zuo; Huangyi Yin; Sien Zeng; Fumio Shimamoto; Guangying Qi
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

Review 3.  Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer.

Authors:  Koh Miura; Wataru Fujibuchi; Kazuyuki Ishida; Takeshi Naitoh; Hitoshi Ogawa; Toshinori Ando; Nobuki Yazaki; Kazuhiro Watanabe; Sho Haneda; Chikashi Shibata; Iwao Sasaki
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

Review 4.  Clinico-pathologic relevance of Survivin splice variant expression in cancer.

Authors:  Rosalia de Necochea-Campion; Chien-Shing Chen; Saied Mirshahidi; Frank D Howard; Nathan R Wall
Journal:  Cancer Lett       Date:  2013-06-18       Impact factor: 8.679

5.  Immunohistochemical expression and serum level of survivin protein in colorectal cancer patients.

Authors:  Katarzyna Jakubowska; Anna Pryczynicz; Violetta Dymicka-Piekarska; Waldemar Famulski; Katarzyna Guzińska-Ustymowicz
Journal:  Oncol Lett       Date:  2016-09-01       Impact factor: 2.967

6.  Nuclear Aurora B and cytoplasmic Survivin expression is involved in lymph node metastasis of colorectal cancer.

Authors:  Handan Tuncel; Fumio Shimamoto; Hiroshi Kaneko Guangying Qi; Eriko Aoki; Hiroshi Jikihara; Shiro Nakai; Takashi Takata; Masaaki Tatsuka
Journal:  Oncol Lett       Date:  2012-03-06       Impact factor: 2.967

7.  Immunohistochemical expression of nuclear and cytoplasmic survivin in gastrointestinal carcinoma.

Authors:  Michiko Shintani; Akiko Sangawa; Naoki Yamao; Shingo Kamoshida
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

8.  Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.

Authors:  Hiroshi Kitamura; Toshihiko Torigoe; Yoshihiko Hirohashi; Hiroko Asanuma; Ryuta Inoue; Sachiyo Nishida; Toshiaki Tanaka; Naoya Masumori; Noriyuki Sato; Taiji Tsukamoto
Journal:  Virchows Arch       Date:  2012-11-20       Impact factor: 4.064

9.  SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer.

Authors:  Wonkyung Jung; Kwang Dae Hong; Woon Yong Jung; Eunjung Lee; Bong Kyung Shin; Han Kyeom Kim; Aeree Kim; Baek-Hui Kim
Journal:  Korean J Pathol       Date:  2013-08-26

10.  Prognostic and clinicopathological significance of survivin in colorectal cancer: a meta-analysis.

Authors:  Andreas Krieg; Thomas A Werner; Pablo E Verde; Nikolas H Stoecklein; Wolfram T Knoefel
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.